Read + Share
Li Y, Chen P, Huang X, Huang H, et al. Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in
AChR-myasthenia gravis patients. J Neuroimmunol 2024;396:578464.
PMID: 39393213
|
 |
|
Li Y, Chen P, Huang X, Huang H, et al. Pathogenic Th17 cells are a potential therapeutic target for tacrolimus in
AChR-myasthenia gravis patients. J Neuroimmunol 2024;396:578464.
PMID: 39393213
|
|
|
|